Viatris Inc.: all 777 studies

Page 5 of 8. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.

• Fasting Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mgCompletedNCT01020214Phase 1
• Fed Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mgCompletedNCT01019590Phase 1
• Fed Study of Mylan Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg and Macrobid® Capsules 100 mgCompletedNCT01018342Phase 1
• Fasting Study of Alendronate Sodium Tablets (70 mg) and Fosamax Tablets (70 mg)CompletedNCT01012934Phase 1
• An Investigation of the Absorption and Pharmacokinetics of Multiple Doses of Three Controlled Release Pregabalin Tablets as Compared to Multiple Doses of the Immediate Release Pregabalin CapsuleCompletedNCT01009541Phase 1
• Effects Of Eplerenone On Serum Aldesterone And Plasma Renin ActivityCompletedNCT00990223Phase 1
• Bioequivalence Study Of Gabapentin Between Tablet And Liquid Formulation And The Food Effect Study Of Liquid FormulationCompletedNCT00987779Phase 1
• Bioequivalence Study of Nisoldipine Extended-Release Tablets, 30 mgCompletedNCT00985660Phase 1
• Fasting Study of Alendronate Sodium Tablets (10 mg) and Fosamax Tablets (10 mg)CompletedNCT00983996Phase 1
• Single-Dose Fed Bioequivalence Study of Nisoldipine Extended-Release Tablets (40 mg; Mylan) and Sular® Extended-Release Tablets (40 mg; First Horizon) in Healthy VolunteersCompletedNCT00979537Phase 1
• Fasting Study of Liothyronine Sodium Tablets (50 Mcg) to Cytomel® Tablets (50 Mcg)CompletedNCT00978055Phase 1
• Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)CompletedNCT00977483Phase 3
• Bioavailability of 3 Sildenafil Oral Disintegrating Tablet Formulations Compared to the Standard Oral TabletCompletedNCT00950404Phase 1
• Pharmacokinetics Of Celecoxib Test FormulationsCompletedNCT00925106Phase 1
• Study Of Bioavailability Of Two Sildenafil 100mg Oral Tablet FormulationsCompletedNCT00902512Phase 4
• Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 StudyNo longer availableNCT00878943
• Bioequivalence Of A Test Alprazolam Sublingual Formulation Compared To A Commercial Sublingual FormulationWithdrawnNCT00877955Phase 1
• Satisfaction With Phosphodiesterase 5 Inhibitors Treatment In Patients With Cardiovascular RiskCompletedNCT00874185
• Pharmacokinetics of Two Eletriptan Oral Formulations Given With and Without Water and the Commercial Tablet Formulation Given With WaterCompletedNCT00871806Phase 1
• Local Open-Label Access Study For Patients Who Completed A1481244 Study In BrazilNo longer availableNCT00866983
• A Study to Compare the Blood Levels of Sildenafil Following Administration of an Experimental Tablet vs. the Conventional Oral Tablet in Healthy SubjectsCompletedNCT00866463Phase 1
• Bioequivalence of Alprazolam Sublingual vs Oral TabletsCompletedNCT00860119Phase 1
• A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In PatientsCompletedNCT00856622Phase 3
• Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the USCompletedNCT00847483Phase 4
• Ziprasidone Pharmacokinetics Using a Reduced Food Effect Formulation Compared to Pharmacokinetics From Commercial CapsulesCompletedNCT00821444Phase 1
• A Pilot Open-Label Crossover Bioavailability Study of Celecoxib in Healthy VolunteersCompletedNCT00813241Phase 1
• Evaluate Pharmacokinetics Of Two Different Pharmaceutical Oral Formulations Of Alprazolam And A Clonazepam Tablet In Mexican Healthy PopulationCompletedNCT00810316Phase 1
• Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy.CompletedNCT00801437
• Sildenafil IV Bolus StudyCompletedNCT00800592Phase 1
• A Study of Glaucoma or Ocular Hypertension in Patients Within the United StatesCompletedNCT00800267Phase 3
• Study to Compare the Blood Levels of Sildenafil Following Administration of an Experimental Tablet vs. the Conventional Oral Tablet in Healthy Subjects.CompletedNCT00795938Phase 1
• Bioequivalence Study On Pediatric Appropriate FormulationCompletedNCT00777517Phase 1
• To Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus ReproterolCompletedNCT00777348Phase 2
• Long-term Effects of Imiquimod and Diclofenac in Actinic KeratosesCompletedNCT00777127Phase 4
• A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00774761Phase 2
• Taste Test of a New Formulation of Sildenafil (Revatio)CompletedNCT00768573
• Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ PatientsCompletedNCT00761371Phase 4
• Bioequivalence Study Of Pediatric Appropriate FormulationCompletedNCT00758004Phase 1
• A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within ScandinaviaCompletedNCT00751062Phase 3
• A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United KingdomCompletedNCT00751049Phase 3
• An Open-Label, Extension Study Evaluating the Safety, Toleration, and Efficacy of Sildenafil in Women With Sexual Arousal DisorderCompletedNCT00746967Phase 2
• Fasting Bioequivalence Study of Nisoldipine Extended-Release Tablets 40 mgCompletedNCT00730197Phase 1
• Epidemiological Study In Hypertensive Patients: Assessment Of Risk Factors Prevalence And Of Patients' ManagementCompletedNCT00709787
• A Study to Evaluate the Efficacy of a Counselling and Advisory Care for Health (COACH) Program in Dyslipidemic Patients.CompletedNCT00708370Phase 4
• A Polysomnographic Study Of Single-Dose Gabapentin In Transient InsomniaCompletedNCT00674752Phase 3
• A Study Of The Efficacy Of Gabapentin In Neuropathic Pain Patients As Measured By Quantitative Sensory TestingCompletedNCT00674687Not applicable
• A Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase AdvanceCompletedNCT00667108Phase 3
• A Study of Single-Dose Gabapentin in Subjects With Transient Insomnia Induced by a Sleep Phase AdvanceCompletedNCT00666939Phase 3
• A Study to Assess the Pharmacodynamic Interaction Between Gabapentin and Ethanol in Healthy SubjectsCompletedNCT00666796Phase 4
• A Polysomnographic Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase AdvanceCompletedNCT00666770Phase 3
• A Study of the Safety of Gabapentin in a Potential Over-the-Counter Population With Occasional SleeplessnessCompletedNCT00666575Phase 3
• A Trial to Assess Consumer Self-Selection and Use of Gabapentin for Occasional Sleeplessness in an Over-the-Counter EnvironmentCompletedNCT00659100Phase 3
• A Study Evaluating the Efficacy and Safety of Sildenafil in Men With Traumatic Spinal Cord Injury and Erectile DysfunctionCompletedNCT00654082Phase 4
• A Study Evaluating the Efficacy and Safety of Sildenafil in Patients With Erectile Dysfunction Receiving HemodialysisCompletedNCT00654017Phase 4
• A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic DisordersCompletedNCT00650611Phase 2
• Food Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mgCompletedNCT00650533Phase 1
• Fed Study of (Parlodel®) 2.5 mg Bromocriptine Mesylate TabletsCompletedNCT00650520Phase 1
• Fed Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mgCompletedNCT00650494Phase 1
• Fasting Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL® Tablets 5 mgCompletedNCT00650481Phase 1
• Evaluation of Adhesion Quality and Irritation of an Alternate Second Generation Estradiol Transdermal SystemCompletedNCT00650442Phase 1
• A Study of the Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective DisorderCompletedNCT00650429Phase 4
• Fasting Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mgCompletedNCT00650416Phase 1
• Food Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mgCompletedNCT00650403Phase 1
• Fed Study of Finasteride Tablets 5 mg and Proscar® Tablets 5 mgCompletedNCT00650377Phase 1
• Fasting Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mgCompletedNCT00650364Phase 1
• Food Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mgCompletedNCT00650351Phase 1
• Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mgCompletedNCT00650325Phase 1
• Fasting Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mgCompletedNCT00650312Phase 1
• Fed Study of Alprazolam Extended-release Tablets 3 mg to Xanax XR® Tablets 3 mgCompletedNCT00650299Phase 1
• Food Study of Modafinil Tablets 200 mg to Provigil® Tablets 200 mgCompletedNCT00650286Phase 1
• Fasting Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mgCompletedNCT00650273Phase 1
• Food Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mgCompletedNCT00650247Phase 1
• Fasting BE Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mgCompletedNCT00650234Phase 1
• Fasting Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Normal Healthy SubjectsCompletedNCT00650221Phase 1
• Fasting Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mgCompletedNCT00650208Phase 1
• Fasting Study of Metolazone Tablets 10 mg and Zaroloxyn® Tablets 10 mgCompletedNCT00650195Phase 1
• Food Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mgCompletedNCT00650169Phase 1
• Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal SystemCompletedNCT00650117Phase 1
• Fasting Study of Cetirizine HCl Tablets 10 mg and Zyrtec® Tablets 10 mgCompletedNCT00650065Phase 1
• Fasting Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mgCompletedNCT00650052Phase 1
• Fed Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mgCompletedNCT00650013Phase 1
• Fasting Study of Modafinil Tablets 200 mg and Provigil® Tablets 200 mgCompletedNCT00650000Phase 1
• Fed Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mgCompletedNCT00649987Phase 1
• Fasting Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mgCompletedNCT00649974Phase 1
• Food BE Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage XR 500 mgCompletedNCT00649948Phase 1
• Fed Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mgCompletedNCT00649935Phase 1
• Evaluation of Adhesion Quality of a New Formulation of the Mylan Estradiol Transdermal System 0.025 mg/Day and Climara® Transdermal System 0.025 mg/DayCompletedNCT00649896Phase 1
• Food Study of Valacyclovir Hydrochloride Tablets 1000 mg to Valtrex® Tablets 1000 mgCompletedNCT00649870Phase 1
• Food Study of Cetirizine HCl Tablets 10 mg and Zyrtec® 10 mgCompletedNCT00649857Phase 1
• A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic DrugsCompletedNCT00649844Phase 3
• Fasting Study of Lorazepam Tablets 2 mg and Ativan Tablets 2 mgCompletedNCT00649818Phase 1
• Fasting Applesauce Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mgCompletedNCT00649805Phase 1
• Fasting Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mgCompletedNCT00649779Phase 1
• Fasting Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mgCompletedNCT00649740Phase 1
• Fed Study of Oxybutynin Chloride Extended-release Tablets 10 mg and Ditropan XL® Tablets 10 mgCompletedNCT00649727Phase 1
• Fed Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mgCompletedNCT00649714Phase 1
• Fasting Study of Metoprolol Tartrate/Hydrochlorothiazide Tablets 100/50 mg and Lopressor HCT® Tablets 100/50 mgCompletedNCT00649688Phase 1
• Food Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mgCompletedNCT00649675Phase 1
• Fasting Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mgCompletedNCT00649662Phase 1
• Food Study of Quinapril Hydrochloride Tablets 40 mg and Accupril® Tablets 40 mgCompletedNCT00649649Phase 1

← Viatris Inc. overview and focus areas